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Abstract
Background: Pregnancy associated cardiovascular pathologies have a significant impact on outcome for mother
and child. Bioimpedance cardiography may provide additional outcome-relevant information early in pregnancy
and may also be used as a predictive instrument for pregnancy-associated diseases.
Methods: We performed a prospective longitudinal cohort trial in an outpatient setting and included 242 pregnant
women. Cardiac output and concomitant hemodynamic data were recorded from 11th–13th week of gestation
every 5th week as well as at two occasions post partum employing bioimpedance cardiography.
Results: Cardiac output increased during pregnancy and peaked early in the third trimester. A higher heart rate
and a decreased systemic vascular resistance were accountable for the observed changes. Women who had a
pregnancy-associated disease during a previous pregnancy or developed hypertension or preeclampsia had a
significantly increased cardiac output early in pregnancy. Furthermore, an effect of cardiac output on birthweight
was found in healthy pregnancies and could be confirmed with multiple linear regression analysis.
Conclusions: Cardiovascular adaptation during pregnancy is characterized by distinct pattern described herein.
These may be altered in women at risk for preeclampsia or reduced birthweigth. The assessment of cardiac
parameters by bioimpedance cardiography could be performed at low costs without additional risks.
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Background
Hemodynamic adaptations during normal pregnancy en-
able the female body to comply with increased metabolic
demands to fulfill fetal requirements. Blood pressure de-
creases during pregnancy as a consequence of vascular
dilatation, which in turn leads to an increase of cardiac
output due to an increased heart rate and a higher
stroke volume [1, 2]. These changes are paralleled by an
increase of cardiac biomarkers like NT-proBNP early
during pregnancy [3].
However, this “stress test” may reveal underlying car-
diovascular diseases [4]. Furthermore, distinct patholo-
gies occur during pregnancy with potential severe
sequels for mother and child [5]. Persistent hyperten-
sion occurs in 12 – 22 % of all pregnancies and may be
associated with preeclampsia [6]. Eclampsia, HELLP-
syndrome and peripartum cardiomyopathy occur more
rarely. Increased vascular resistance, high blood pres-
sure, pathologic endothelial function and lower plasma
volume characterize preeclampsia, which has an esti-
mated incidence up to 5 % [7]. Diagnostic criteria for
preeclampsia are the onset of hypertension after the
20th week of gestation, measured on two different occa-
sions and proteinuria [8].
The assessment of cardiac output and systemic vascu-
lar resistance adds significant information to blood pres-
sure and heart rate. As a key finding in prior trials, an
increased cardiac output could be detected as early as in
the 10th–14th week of gestation in women who devel-
oped preeclampsia or gestational hypertension later in
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pregnancy [9]. Thus, the early and significant difference
in cardiac output compared to healthy pregnancies may
be used as a diagnostic tool for early identification of
women at risk for preeclampsia or gestational hyperten-
sion. Furthermore, a decrease of cardiac output and an
increase of blood pressure during the clinical onset of
preeclampsia was reported [10]. This crossover was not
detected in patients with gestational hypertension and
supports the hyperdynamic disease model for preeclampsia.
The gold standard for the assessment of cardiac output
is thermodilution using a cardiac catheter [11]. Although
this is a suitable method for intensive care patients, it
cannot be applied in an outpatient setting for repeated
measurements in pregnant women. Echocardiography
was previously applied to elucidate cardiovascular adap-
tations during pregnancy [12]. However, measurements
are time consuming, technical demanding and investiga-
tor–dependent. Therefore, it gained no widespread use
for screening purposes in an outpatient setting.
We decided to perform a prospective trial in order to
establish the applicability of bioimpedance cardiography
for the assessment of cardiovascular parameters during
pregnancy [13]. Several authors reported the reliable ap-
plication of this technique in healthy pregnant women
and patients suffering from preeclampsia, but large pro-
spective cohort trials are scarce [14–18].
Methods
Between 2006 and 2009, 242 pregnant women were in-
cluded in this prospective cohort study after providing
written informed consent. A high number of women
were included to evaluate also disease processes not pri-
marily present and occurring throughout the pregnancy.
The local ethics committee approved the study protocol
(EK 619/2006). We measured cardiovascular parameters
noninvasively by monitoring the tissue impedance of dis-
tinct thoracic regions [18]. An impedance cardiography
monitor was used for non-invasive measurement of car-
diac output, heart rate, blood pressure, systemic vascular
resistance and stroke volume (ICG hemodynamic meas-
urement, Philips Medical Systems, Andover, MA, USA;
www.medical.philips.com). Two pairs of electrodes were
placed on the neck and two pairs were placed on the
trunk, respectively. Every measurement was performed
in a quiet room after a resting period of 10 min. The
automatic assessment and data printout were performed
after stable readings could have been achieved. To esti-
mate the hemodynamic influence of a growing fetus
compressing the Vena cava in a supine position, every
measurement was performed in supine as well as in side
position. Cardiac output and not cardiac index was
chosen for all analysis hence previous results indicated a
low correlation of cardiac output to body surface area
during pregnancy [19].
Women were asked to participate in this study at their
routine visit for the first ultrasound control at the out-
patient department of the obstetrics and gynecology
clinic usually performed between the 11th–13th week of
gestation. Patients with pre-existing diabetes, cardiac
disease (e.g. previous surgery, significant aortic stenosis
and other preexisting anatomic lesions) or intravenous
drug abuse were not included. Every visit included med-
ical history assessment, a physical examination to diag-
nose symptoms of preeclampsia and other pregnancy
related diseases, an ECG and the measurement of car-
diac output, blood pressure, heart rate, systemic vascular
resistance and stroke volume. Cardiac output and con-
comitant data were recorded at the 11th–13th, 14th–17th,
18th–22nd, 23rd–27th, 28th–32nd, 33rd–36th and after the
37th week of gestation as well as six weeks and six
months post partum. Every onset of a pregnancy related
disease was recorded, evaluated and treated according to
current guidelines [8]. Preeclampsia was defined as the
new onset of hypertension and proteinuria in human
pregnancy after the 20th week of gestation [8]. The ges-
tational age was calculated from the first day of the last
menstrual bleeding and was corrected according to sono-
graphic measurements (fetal crown to rump length).
Patient grouping
A flow chart was added to depict final patient groups for
the analysis performed in this study (Fig. 1). Pre-existing
illnesses comprised hypertension (n = 28) and thyroid
gland disease (n = 18; hypothyreosis 14, hyperthyreosis
4). Nine patients suffered from gestational diabetes mel-
litus during a previous pregnancy. Nine patients had a
family history of preeclampsia. Due to a low number or
heterogonous groups, patients with the aforementioned
Fig. 1 Flowchart of studied patient groups
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characteristics were not analyzed as specific group.
However, patients with previous pregnancy related
hypertension (n = 17), previous preeclampsia (n = 7) or
previous HELLP syndrome (n = 6) were grouped (n = 29)
and compared to the healthy control group.
During the pregnancy under investigation, patients were
diagnosed with preeclampsia (n = 6), new onset of hyper-
tension (n = 5), gestational diabetes mellitus (n = 12) and
HELLP syndrome (n = 2). In addition, abnormal Doppler
(n = 4) and preterm labor (n = 9) were recorded.
All women without any previous or current relevant
disease described herein were classified as healthy and
grouped for analysis (n = 128). However, six women
had a twin pregnancy and were, although healthy, not
included in the “healthy” group due to changed
hemodynamic parameters in twin pregnancies.
Statistical analysis
Data sets were descriptively analyzed and are presented
as means ± SD. For comparison of data, sets were tested
for normal distribution (Shapiro-Wilk test). To compare
outcome parameters between groups of healthy and
pathologic pregnancies, an analysis of variance was
performed. The Pearson correlation coefficient was cal-
culated to analyze relationships. Time points were
compared pair-wise with a Sidak correction for the sig-
nificance level due to the multiple comparisons applied
herein. A multiple linear regression was performed to
assess the effect of cardiac output on birthweight in-
cluding maternal age, body mass index and smoking
habit. p-values (two-sided) lower than 0.05 were con-
sidered statistically significant. Statistical analysis was
performed with SPSS 21 (SPSS Inc., Chicago, Illinois,
USA). Figures were calculated and drawn by applying
the spline function. Single data points were printed for
comparisons with a low number of measurements.
Results
Demographic characteristics of healthy and diseased
pregnancies are shown in Table 1. We performed all
measurements in the supine and side position to identify
position dependent influences on hemodynamic parame-
ters (Table 2, Fig. 2). A significant difference in cardiac
output and stroke volume between supine and side pos-
ition in healthy women (n = 128) was only present in the
33rd–36th week of gestation. A significant and high cor-
relation of cardiovascular parameters between body po-
sitions was present throughout pregnancy (Table 2). All
further comparisons were performed with measurements
in the side position.
Cardiac output in the 33rd–36th week of gestation was
significantly increased compared to 11th–13th week (p =
0.008) and compared to post-delivery (Fig. 3a; p = 0.001).
Heart rate was significantly increased from the 23rd week
of gestation compared to 11th–13th week (p < 0.001) and
compared to post-delivery (Table 2; p = 0.002). Systolic
blood pressure and stroke volume showed no significant
difference throughout pregnancy and after delivery
(Table 2, Fig. 3b). However, diastolic blood pressure was
significantly higher after the 34th week of gestation com-
pared to 14th – 22nd week of gestation (Table 2, Fig. 3b;
p < 0.02). Furthermore, systemic vascular resistance was
significantly lower in the 33rd–36th week of gestation
compared to 11th–13th week (p = 0.009) and compared
to post-delivery (Fig. 3a; p = 0.006).
Table 1 Demographics, pregnancy characteristics and risk factors
Group Healthy Prev. HTN/PRE p-value HTN/PRE p-value
Demographics
Age years 32 ± 6 35 ± 5 0.010 34 ± 6
Height cm 164 ± 16 165 ± 7 166 ± 6
Weight kg 63 ± 13 78 ± 19 <0.001 80 ± 24 <0.001
BMI kg/m2 23.2 ± 4.3 29.0 ± 7.5 <0.001 28.6 ± 7.9 <0.001
Pregnancy details
Pregnancy n 2 ± 2 3 ± 2 3 ± 1
Birthweight g 3334 ± 539 2351 ± 1314 <0.001 2418 ± 1076 <0.001
Gestational week of birth week 39 ± 2 35 ± 7 <0.001 36 ± 4 0.002
Previous diseases/risks
Kidney disease % 0 0 0
Thyroid gland disease % 0 3 0.035 9 0.001
Hypertension % 0 38 <0.001 27 <0.001
Smoking % 26 17 11
Caption: Prev. HTN/PRE: patients with a previous pregnancy related hypertension or preeclampsia are presented in this group; HTN/PRE: Patients who developed
hypertension or preeclampsia during the pregnancy under investigation are grouped herein; p-values are calculated against healthy group
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Women with preeclampsia, HELLP syndrome or hyper-
tension in a previous pregnancy were grouped and ana-
lyzed (Table 3, Fig. 4a; n = 29). This group had
significantly increased cardiac output and heart rate in the
first months and a significantly increased blood pressure
throughout pregnancy. Eleven patients had a previously
diagnosed hypertension, two patients developed pre-
eclampsia, two patients developed HELLP syndrome, two
patients had an abnormal Doppler and two patients suf-
fered from preterm delivery.
Patients with a new onset of pregnancy related hyper-
tension during this pregnancy had a significantly in-
creased cardiac output due to an increased stroke volume
compared to the healthy group (Fig. 4b). Patients who de-
veloped preeclampsia had a significantly elevated blood
pressure throughout pregnancy (p < 0.01). In addition, car-
diac output was significantly increased from 5.2 to 6.8 l/
min at 11th–13th week of gestation compared to the
healthy group due to an increased stroke volume (Fig. 4c;
p = 0.04). Cardiac output was no longer increased from
Table 2 Hemodynamic parameters in healthy pregnancy (n = 128)
week 11th-13th 14th-17th 18th-22nd 23rd-27th 28th-32nd 33rd-36th 37th-40th 6th week 6th month
CO l/min 5.3 ± 1.1 5.2 ± 1.1 5.3 ± 1.0 5.8 ± 1.2 5.8 ± 1.1 5.8 ± 1.3 5.8 ± 1.1 4.5 ± 0.7 4.8 ± 1.1
CO-SP l/min 5.3 ± 1.2 5.2 ± 1.2 5.4 ± 1.0 5.7 ± 1.2 5.8 ± 1.2 6.1 ± 1.3 5.5 ± 1.1 4.5 ± 0.8 4.7 ± 1.0
p-value 0.021
Correlation Pearson 0.80 0.85 0.80 0.85 0.78 0.78 0.74 0.62 0.69
HR beats/min 78 ± 10 81 ± 11 83 ± 11 87 ± 16 94 ± 13 93 ± 13 90 ± 13 76 ± 11 76 ± 10
HR-SP beats/min 78 ± 10 81 ± 10 82 ± 11 88 ± 11 93 ± 13 91 ± 12 89 ± 15 74 ± 10 76 ± 10
p-value
Correlation Pearson 0.60 0.86 0.78 0.72 0.66 0.57 0.54 0.87 0.70
BP-sys mmHg 107 ± 10 102 ± 9 102 ± 9 103 ± 9 105 ± 9 105 ± 7 107 ± 10 103 ± 8 106 ± 7
BP-dia mmHg 71 ± 8 69 ± 7 69 ± 7 71 ± 6 72 ± 8 74 ± 6 76 ± 8 71 ± 6 74 ± 7
SVR dyn · s/cm5 1245 ± 245 1218 ± 241 1190 ± 214 1176 ± 253 1116 ± 206 1169 ± 282 1220 ± 251 1414 ± 230 1378 ± 288
SVR-SP dyn · s/cm5 1292 ± 233 1255 ± 256 1205 ± 284 1174 ± 335 1139 ± 234 1097 ± 224 1244 ± 253 1422 ± 274 1453 ± 312
p-value 0.036 0.009
Correlation Pearson 0.76 0.79 0.66 0.85 0.74 0.79 0.71 0.71 0.70
SV l/min 69 ± 13 66 ± 14 67 ± 13 65 ± 14 64 ± 13 63 ± 16 65 ± 14 62 ± 14 66 ± 18
SV-SP l/min 67 ± 13 66 ± 15 67 ± 13 66 ± 14 64 ± 14 68 ± 14 66 ± 16 62 ± 12 62 ± 15
p-value <0.001
Correlation Pearson 0.75 0.84 0.65 0.84 0.76 0.88 0.73 0.72 0.85
CO cardiac output, CO-SP cardiac output in side position, HR heart rate, HR-SP heart rate in side position, BP-sys systolic blood pressure, BP-dia diastolic blood
pressure, SVR systemic vascular resistance, SVR-SP systemic vascular resistance in side position, SV stroke volume, SV-SP stroke volume in side position; only
significant p-values are shown are shown for differences between the two positions. All correlations are significant
Fig. 2 Cardiac output during healthy pregnancy (n = 128). Caption: CO: cardiac output; blue: supine position; green: side position; *: p < 0.05;
pp: post-partum
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the 14th week of gestation, but systemic vascular resistance
was significantly increased (1650 ± 665 dyn · s/cm5 com-
pared to 1255 ± 256 dyn · s/cm5; p < 0.05).
Fetal outcome in healthy pregnant women
A correlation analysis of cardiac output and systemic
vascular resistance with birthweight in healthy women
revealed a positive correlation for cardiac output and a
negative correlation for systemic vascular resistance. The
Pearson correlation coefficient for cardiac output was
0.32 (p = 0.014), 0.42 (p = 0.006) and 0.32 (p = 0.058) for
the 23rd–27th, 28th–32nd and 33rd–37th week of gesta-
tion, respectively. Concordantly, the Pearson correlation
coefficient for systemic vascular resistance was −0.41
(p = 0.004), −0.33 (p = 0.033) and −0.31 (p = 0.061) for
the 23rd–27th, 28th–32nd and 33rd–37th week of gesta-
tion, respectively. A multiple linear regression analysis
including cardiac output, maternal age, body mass
index and smoking habit revealed cardiac output as the
only independent predictor for birthweight (p = 0.032
and p = 0.028 for the 23rd–27th and the 28th–32nd week
of gestation, respectively). Furthermore, birthweight
and gestational age were significantly reduced in
hypertensive pregnancies to 2548 ± 903 g at 37 ±
5 weeks compared to 3308 ± 554 g at 39 ± 2 weeks in
healthy pregnancies (p < 0.001 for birthweight and p = 0.03
for gestational age).
Discussion
The assessment of cardiovascular parameters utilizing
bioimpedance cardiography during pregnancy was per-
formed in a number of previous trials and showed reli-
able results [15–18, 20, 21]. We present a large cohort
study with longitudinal measurements in different pa-
tient positions compared to previous trials [22]. The in-
fluence of body position on maternal hemodynamic
parameters in healthy pregnancies was assessed and a
significant reduction of cardiac output due to a reduced
stroke volume was observed at the 33rd–36th week of
gestation in supine position [14]. The significant influ-
ence of body position on cardiac output in the third tri-
mester of pregnancy is in accordance with previous
findings [23]. However, our data prove that body pos-
ition is only relevant to cardiac parameters towards
the end of pregnancy. However, we decided to use
Fig. 3 Hemodynamic parameters in healthy pregnancy (n = 128). Caption: a) CO: cardiac output; SVR: systemic vascular resistance; b) blood
pressure; pp: post-partum
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hemodynamic data acquired in the side position for all
further comparisons described herein.
Cardiac output increased constantly towards the 35th
week of gestation in healthy pregnancies, which is con-
cordant with previous results [1, 2]. However, stroke vol-
ume did not change significantly during healthy
pregnancy. We conclude therefore, that stroke volume
was not responsible for the increased cardiac output.
Our data suggest that systemic vascular resistance,
which was already decreased at inclusion and further de-
creased until the 24th week of gestation, drives cardiac
output by reduced afterload and a higher heart rate.
Compared to the results of San-Frutos et al., systemic
vascular resistance was relatively stable thereafter until
close to delivery and showed no increase after the 24th
week of gestation [17]. This difference may be due to
our higher number of observations and different meas-
urement equipment. Our data are further supported by
Bosio et. al., who measured hemodynamic parameters by
echocardiography and showed a similar time course of
systemic vascular resistance [9]. Heart rate also in-
creased continuously from the 24th week on and the dia-
stolic blood pressure increased close to delivery. Both
findings are in good agreement with the data presented
by Volman et al., but the distinct pattern of cardiac
output during pregnancy is still under debate [1]. A re-
cent meta-analysis by Meah et al., concluding previous
trials, highlighted the ongoing discussion regarding
cardiac output especially in the third trimester [22].
Our results add to this discussion and support the re-
sults of the meta-analysis regarding a drop of cardiac
output close to term. However, we did not exhibit an
earlier drop of cardiac output at the end of the second
trimester, which had been suggested based on the
meta-analysis, but was not confirmed or rejected previ-
ously with data from a large cohort trial [22]. We
therefore believe that our results are a relevant
addition to the current data regarding cardiac output
in healthy pregnancies.
In addition to the healthy population, special groups
of patients presenting a cardiovascular or pregnancy asso-
ciated pathology or are at risk to develop one of these dis-
orders were included. Women with previous pregnancy
associated hypertension or preeclampsia had a different
hemodynamic profile throughout pregnancy compared to
healthy pregnancies without previous pathologies. A long-
lasting effect on cardiovascular compliance after preg-
nancy was previously described in healthy pregnancies
[24]. This may also be true after pathologic pregnancies.
Furthermore, underlying risk factors inducing the
hemodynamic alterations may still be present in these
women. Significant adverse outcomes are reported in this
group [25]. We suggest that a previous pregnancy associ-
ated disease may be a risk factor for adverse hemodynamic
behavior in a consecutive pregnancy. The screening for
disturbed cardiovascular adaptation during pregnancy
Table 3 Previous pregnancy related disease (n = 29) and healthy controls (n = 128)
week 11th-13th 14th-17th 18th-22nd 23rd-27th 28th-32nd 33rd-36th 37th-40th 6th week 6th month
CO prev. dis. 6.3 ± 2.2 5.5 ± 1.1 6.2 ± 1.5 6.3 ± 1.4 6.4 ± 1.7 6.1 ± 1.5 5.4 ± 1.6 5.0 ± 1.3 4.7 ± 0
l/min healthy 5.3 ± 1.2 5.2 ± 1.2 5.4 ± 1.0 5.7 ± 1.2 5.8 ± 1.2 6.1 ± 1.3 5.5 ± 1.1 4.5 ± 0.8 4.7 ± 1.0
p-value 0.017 0.012
HR prev. dis. 85 ± 9 85 ± 14 90 ± 8 91 ± 14 92 ± 13 91 ± 10 100 ± 10 72 ± 11 82 ± 0
beats/min healthy 79 ± 10 81 ± 11 83 ± 11 88 ± 12 94 ± 14 91 ± 14 89 ± 15 74 ± 10 76 ± 10
p-value 0.021 0.003
BP-sys prev. dis. 124 ± 15 117 ± 16 119 ± 13 115 ± 11 112 ± 11 115 ± 18 112 ± 14 113 ± 5 96 ± 0
mmHg healthy 107 ± 11 103 ± 7 104 ± 8 102 ± 10 104 ± 10 104 ± 9 107 ± 10 103 ± 7 106 ± 7
p-value <0.001 <0.001 <0.001 <0.001 0.009 0.003 0.028
BP-dia prev. dis. 85 ± 21 80 ± 11 79 ± 10 79 ± 9 76 ± 8 79 ± 11 81 ± 9 76 ± 6 67 ± 0
mmHg healthy 73 ± 8 69 ± 7 70 ± 7 71 ± 7 72 ± 9 73 ± 8 76 ± 8 70 ± 7 74 ± 7
p-value <0.001 <0.001 <0.001 0.001 0.064 0.035
SVR prev. dis. 1444 ± 698 1389 ± 356 1257 ± 469 1170 ± 292 1093 ± 248 1222 ± 360 1422 ± 447 1400 ± 271 1260 ± 0
dyn · sec/cm5 healthy 1292 ± 233 1255 ± 256 1205 ± 284 1174 ± 335 1139 ± 234 1097 ± 224 1244 ± 253 1422 ± 274 1453 ± 312
p-value
SV prev. dis. 74 ± 22 66 ± 16 70 ± 16 71 ± 16 72 ± 14 69 ± 14 58 ± 16 70 ± 15 63 ± 0
l/min healthy 67 ± 13 66 ± 15 67 ± 13 66 ± 14 64 ± 14 68 ± 14 66 ± 16 62 ± 12 62 ± 15
p-value 0.063
CO cardiac output, HR heart rate, BP-sys: systolic blood pressure, BP-dia: diastolic blood pressure, SVR systemic vascular resistance, SV stroke volume; all
measurements are performed in side position, only significant and borderline significant p-values are shown
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may therefore be beneficial for women with a history of
pregnancy-associated disease.
In addition, we were able to measure cardiac parame-
ters prior to disease onset and could provide insights in
early adverse alterations of hemodynamic function. An
increased cardiac output during early pathologic preg-
nancy was previously described and supports the hy-
pothesis of a hyperdynamic hemodynamic state inducing
preeclampsia [9, 26]. The increase of systemic vascular
resistance later in pregnancy leads to hypertension and a
reduction of cardiac output [10]. Bioimpedance cardiog-
raphy may provide additional information for patients at
risk for preeclampsia. However, distinct hemodynamic
characteristics of these patient groups should further be
specified in a multicenter trial.
Interestingly, cardiac output showed an impact on
birthweight in healthy pregnancies. Altered cardiovascu-
lar conditions in pregnancies with fetal growth restric-
tions were previously reported and are in good
accordance with our data [2, 21, 27, 28]. In addition to
previous trials, our results indicate that these changes
may also appear early in otherwise healthy pregnancies
and can be measured by bioimpedance cardiography
[20]. These findings should also be reevaluated in larger
Fig. 4 Cardiac output in healthy women and patients during pregnancy. Caption: a) Patients with previous pregnancy associated hypertension or
preeclampsia (blue) compared to healthy women (green); b) patients developing hypertension during the current pregnancy (blue) compared to
healthy women (green); c) patients developing preeclampsia (blue) compared to healthy women (green); CO: cardiac output; pp: post-partum
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clinical trials. Patients identified to be “at risk” by bioim-
pedance cardiography may undergo further cardiovascu-
lar workup and increased clinical controls until birth.
Gestational age and birthweight were also significantly
decreased in hypertensive women. No significant differ-
ence between treated and untreated women could be
detected. Previous trials reported conflicting results
whether chronic hypertension impacts fetal outcome
[29, 30]. However, the difference in birthweight seems
much more pronounced than in gestational age, which
may indicate a growth restriction in these pathologies
independent of gestational age.
Limitations
Although this prospective cohort trial included a high
number of pregnant women compared to other trials,
the number of patients diagnosed with preeclampsia and
new onset of hypertension is limited. Therefore, the find-
ings in these subgroups have to be interpreted with caution.
Further, not all patients participated in all measurement
time points. Some groups were not analysed due to the
limited number of patients (thyroid disease, gestational dia-
betes and twin pregnancies). Measurements in pathologic
groups were not analyzed in relation to the body mass
index due to the limited number of observations.
Conclusion
In conclusion, cardiovascular adaptation during pregnancy
is altered in women at risk for preeclampsia or reduced
birthweigth. Distinct hemodynamic pattern were present
early in pregnancy and could be assessed by bioimpedance
cardiography at low costs without additional risk.
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